Researchers at King's College London and other institutions are investigating whether 'AI-associated psychosis' should be recognized as a clinical diagnosis, according to The Decoder. This consideration arises from growing concerns around mental health effects linked to interactions with AI chatbots.
OpenAI's self-reported data indicates that approximately 560,000 users exhibit signs of psychosis or mania each week, highlighting the scale of potential mental health impacts related to AI technology. These findings prompt deeper examination into the psychological consequences of AI engagement.
For Japanese markets, where AI adoption in finance and trading is increasing, understanding these mental health risks is crucial for managing both user wellbeing and market stability amid growing AI integration.